Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Outset Medical (OM) Shares Outstanding (2018 - 2026)

Outset Medical has reported Shares Outstanding over the past 8 years, most recently at $18.2 million for Q4 2025.

  • Quarterly Shares Outstanding rose 414.7% to $18.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.2 million through Dec 2025, up 414.7% year-over-year, with the annual reading at $18.2 million for FY2025, 414.7% up from the prior year.
  • Shares Outstanding was $18.2 million for Q4 2025 at Outset Medical, up from $17.8 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $47.2 million in Q4 2021 and troughed at $21000.0 in Q1 2025.
  • The 5-year median for Shares Outstanding is $49629.0 (2023), against an average of $6.6 million.
  • The largest YoY upside for Shares Outstanding was 110477.69% in 2021 against a maximum downside of 99.89% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $47.2 million in 2021, then crashed by 99.9% to $48295.0 in 2022, then soared by 6844.82% to $3.4 million in 2023, then increased by 5.25% to $3.5 million in 2024, then soared by 414.7% to $18.2 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Shares Outstanding are $18.2 million (Q4 2025), $17.8 million (Q3 2025), and $21000.0 (Q2 2025).